help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on December 20, 2007, doi:10.1165/rcmb.2007-0279RC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0279RCv1
38/3/256    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, L. P.
Right arrow Articles by Bond, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, L. P.
Right arrow Articles by Bond, R. A.
American Journal of Respiratory Cell and Molecular Biology. Vol. 38, pp. 256-262, 2008
© 2008 American Thoracic Society
DOI: 10.1165/rcmb.2007-0279RC

Rapid Communication

Chronic Exposure to Beta-Blockers Attenuates Inflammation and Mucin Content in a Murine Asthma Model

Long P. Nguyen1, Ozozoma Omoluabi2, Sergio Parra1, Joanna M. Frieske1, Cecilia Clement3,4, Zoulikha Ammar-Aouchiche3,4, Samuel B. Ho5, Camille Ehre6, Mehmet Kesimer6, Brian J. Knoll1, Michael J. Tuvim3,4, Burton F. Dickey3,4 and Richard A. Bond1

1 Department of Pharmacological and Pharmaceutical Sciences, and 2 Department of Biology and Biochemistry, University of Houston, Houston, Texas; 3 Department of Pulmonary Medicine, M.D. Anderson Cancer Center, Houston, Texas; 4 Institute of Biosciences and Technology, Texas A&M University System Houston Health Science Center, Houston, Texas; 5 Department of Medicine, Veterans Affairs San Diego Healthcare System and University of California, San Diego, California; and 6 Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, North Carolina

Correspondence and requests for reprints should be addressed to Richard A. Bond, Ph.D, Department of Pharmacological and Pharmaceutical Sciences, University of Houston, College of Pharmacy, 4800 Calhoun, Houston, TX 77204-5037. E-mail: RABond{at}uh.edu

Single-dose administration of beta-adrenoceptor agonists produces bronchodilation and inhibits airway hyperresponsiveness (AHR), and is the standard treatment for the acute relief of asthma. However, chronic repetitive administration of beta-adrenoceptor agonists may increase AHR, airway inflammation, and risk of death. Based upon the paradigm shift that occurred with the use of beta-blockers in congestive heart failure, we previously determined that chronic administration of beta-blockers decreased AHR in a murine model of asthma. To elucidate the mechanisms for the beneficial effects of beta-blockers, we examined the effects of chronic administration of several beta-adrenoceptor ligands in a murine model of allergic asthma. Administration of beta-blockers resulted in a reduction in total cell counts, eosinophils, and the cytokines IL-13, IL-10, IL-5, and TGF-β1 in bronchoalveolar lavage, and attenuated epithelial mucin content and morphologic changes. The differences in mucin content also occurred if the beta-blockers were administered only during the ovalbumin challenge phase, but administration of beta-blockers for 7 days was not as effective as administration for 28 days. These results indicate that in a murine model of asthma, chronic administration of beta-blockers reduces inflammation and mucous metaplasia, cardinal features of asthma that may contribute to airflow obstruction and AHR. Similar to heart failure, our results provide a second disease model in which beta-blockers producing an acutely detrimental effect may provide a therapeutically beneficial effect with chronic administration.

Key Words: beta-blockers • beta-adrenoceptor • asthma • mucin • airway inflammation


CLINICAL RELEVANCE

This research may result in a paradigm shift in the treatment of asthma. This research demonstrates the importance that duration of beta-blocker therapy has on clinical and physiologic responses.

 



This article has been cited by other articles:


Home page
 Eur Heart JHome page
A. F. Folino, M. L. Scapellato, C. Canova, P. Maestrelli, G. Bertorelli, L. Simonato, S. Iliceto, and M. Lotti
Individual exposure to particulate matter and the short-term arrhythmic and autonomic profiles in patients with myocardial infarction
Eur. Heart J., July 1, 2009; 30(13): 1614 - 1620.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. M. Shaw and S. G. Williams
Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma?
Eur. Heart J., May 2, 2009; 30(10): 1287 - 1287.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. Tuvim, A. R. Mospan, K. A. Burns, M. Chua, P. J. Mohler, E. Melicoff, R. Adachi, Z. Ammar-Aouchiche, C. W. Davis, and B. F. Dickey
Synaptotagmin 2 Couples Mucin Granule Exocytosis to Ca2+ Signaling from Endoplasmic Reticulum
J. Biol. Chem., April 10, 2009; 284(15): 9781 - 9787.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Livraghi, B. R. Grubb, E. J. Hudson, K. J. Wilkinson, J. K. Sheehan, M. A. Mall, W. K. O'Neal, R. C. Boucher, and S. H. Randell
Airway and Lung Pathology Due to Mucosal Surface Dehydration in {beta}-Epithelial Na+ Channel-Overexpressing Mice: Role of TNF-{alpha} and IL-4R{alpha} Signaling, Influence of Neonatal Development, and Limited Efficacy of Glucocorticoid Treatment
J. Immunol., April 1, 2009; 182(7): 4357 - 4367.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. P. Nguyen, R. Lin, S. Parra, O. Omoluabi, N. A. Hanania, M. J. Tuvim, B. J. Knoll, B. F. Dickey, and R. A. Bond
From the Cover: {beta}2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model
PNAS, February 17, 2009; 106(7): 2435 - 2440.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. B. Penn
Agonizing over agonism: Should asthmatics turn their {beta}-receptors on or off?
PNAS, February 17, 2009; 106(7): 2095 - 2096.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. L. Chupp
Say What, Beta-Blockers for Asthma?
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 249 - 250.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society. 		  CCM abstracts